Nuveen Asset Management’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$7.24M Sell
355,057
-360,243
-50% -$7.34M ﹤0.01% 1785
2024
Q3
$20.8M Sell
715,300
-358,557
-33% -$10.4M 0.01% 1165
2024
Q2
$24.9M Buy
1,073,857
+565,661
+111% +$13.1M 0.01% 987
2024
Q1
$10.4M Buy
508,196
+188,759
+59% +$3.87M ﹤0.01% 1561
2023
Q4
$6.86M Sell
319,437
-44,228
-12% -$949K ﹤0.01% 1798
2023
Q3
$7.5M Sell
363,665
-1,791
-0.5% -$36.9K ﹤0.01% 1644
2023
Q2
$10.8M Buy
365,456
+4,820
+1% +$142K ﹤0.01% 1470
2023
Q1
$8.31M Sell
360,636
-15,111
-4% -$348K ﹤0.01% 1602
2022
Q4
$10.4M Buy
375,747
+24,288
+7% +$675K ﹤0.01% 1460
2022
Q3
$10.8M Sell
351,459
-8,699
-2% -$267K ﹤0.01% 1428
2022
Q2
$10.6M Sell
360,158
-10,071
-3% -$296K ﹤0.01% 1467
2022
Q1
$12.3M Sell
370,229
-6,815
-2% -$227K ﹤0.01% 1514
2021
Q4
$16.8M Buy
377,044
+11,966
+3% +$534K 0.01% 1333
2021
Q3
$19.3M Sell
365,078
-18,982
-5% -$1M 0.01% 1297
2021
Q2
$30.1M Buy
384,060
+106,439
+38% +$8.35M 0.01% 1069
2021
Q1
$15.9M Sell
277,621
-14,241
-5% -$813K 0.01% 1490
2020
Q4
$24.4M Sell
291,862
-36,489
-11% -$3.06M 0.01% 1121
2020
Q3
$11.8M Sell
328,351
-1,328
-0.4% -$47.6K ﹤0.01% 1416
2020
Q2
$7.97M Buy
329,679
+46,241
+16% +$1.12M ﹤0.01% 1641
2020
Q1
$4.96M Buy
283,438
+103,045
+57% +$1.8M ﹤0.01% 1720
2019
Q4
$3.14M Buy
180,393
+1,163
+0.6% +$20.3K ﹤0.01% 2233
2019
Q3
$2.75M Buy
179,230
+4,255
+2% +$65.2K ﹤0.01% 2256
2019
Q2
$3.63M Buy
+174,975
New +$3.63M ﹤0.01% 2155